Herpes Zoster: all 370 studies
Page 4 of 4. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.
- Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in SpainCompletedNCT01521286
- Safety of Zostavax Vaccination in Rheumatoid ArthritisCompletedNCT01506661Phase 1
- Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes ZosterCompletedNCT01327144Phase 3
- Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster VaccineCompletedNCT01288014
- Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care ResidentsCompletedNCT01262300Phase 1
- Reduction of Postherpetic Neuralgia in Herpes ZosterCompletedNCT01250561Not applicable
- Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-StudyWithdrawnNCT01213810Phase 1/2
- Development of a Bedside Pain Assessment Kit for Postherpetic NeuralgiaStatus unknownNCT01166295
- Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisCompletedNCT01160081
- The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected ChildrenCompletedNCT01138215Phase 4
- ZOSTAVAX® in Renal Transplant PatientsCompletedNCT01137669Phase 1
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting ConditionsCompletedNCT01132729Not applicable
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed ConditionsCompletedNCT01132716Not applicable
- Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese AdultsCompletedNCT01086449Phase 1
- Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector DeliveryStatus unknownNCT00926419Phase 2/3
- Immune Response to Varicella-Zoster Vaccination and InfectionCompletedNCT00921999
- A Study of FV-100 Versus Valacyclovir in Patients With Herpes ZosterCompletedNCT00900783Phase 2
- Acupuncture in Herpes Zoster Neuralgia (ACUZoster)CompletedNCT00885586Phase 4
- A Phase 2b Trial of EPB-348 for the Treatment of Herpes ZosterCompletedNCT00831103Phase 2
- Safety of a Second Dose of Biken's Varicella VaccineCompletedNCT00830648Phase 4
- The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy SettingCompletedNCT00689013Not applicable
- The Effectiveness of Varicella Vaccination in Children in GermanyCompletedNCT00679796
- Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)Status unknownNCT00652184Phase 2
- Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus InfectionsCompletedNCT00642785
- Varicella Vaccination With PulmicortCompletedNCT00641446Phase 4
- A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)CompletedNCT00576108Phase 2
- Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in ThailandCompletedNCT00526864
- VZV PCR Sampling Validation StudyCompletedNCT00501670
- An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).CompletedNCT00492323Phase 2
- Dose-finding Study of ASP2151 in Subjects With Herpes ZosterCompletedNCT00487682Phase 2
- ZOSTAVAX(R) Local Registration Trial (V211-019)CompletedNCT00444860Phase 3
- Safety Study of a Refrigerator-stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
- Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)CompletedNCT00432523Phase 3
- Efficacy of TCA Effect on Varicella Atrophic ScarsStatus unknownNCT00422539Phase 2
- Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
- Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™CompletedNCT00353288Phase 2
- Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™CompletedNCT00352898Phase 2
- Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With PlaceboTerminatedNCT00352651Phase 2
- Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration RoutesCompletedNCT00351923Phase 3
- Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella InfectionApproved for marketingNCT00338442
- Evolution of Pain From Herpes ZosterCompletedNCT00305357
- Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00300222Phase 3
- Immune Responses to Two Dose Varivax +/- MMR-IITerminatedNCT00258726Phase 1/2
- Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)CompletedNCT00233155Phase 2
- The Safety of Oka Varicella in Children Prior to Solid Organ TransplantationCompletedNCT00213304Phase 3
- Evaluation Of Valaciclovir In Patients With ChickenpoxCompletedNCT00169416Phase 3
- Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
- Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
- Shingles: Immune Effects of Tai ChiCompletedNCT00118885Phase 2
- Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00115310Phase 3
- Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)CompletedNCT00109122Phase 2
- Dose-Finding Study of REN-1654 in Patients With Post-Herpetic NeuralgiaStatus unknownNCT00099528Phase 2
- Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster InfectionCompletedNCT00098046Phase 3
- Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
- An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic PainTerminatedNCT00089557Phase 2
- Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainCompletedNCT00082316Phase 2
- Controlled Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00068081Phase 3
- NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00061776Phase 2/3
- Valacyclovir in Immunocompromised ChildrenCompletedNCT00059592Phase 1
- Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia PainCompletedNCT00034710Phase 2
- Tai Chi Chih and Varicella Zoster ImmunityCompletedNCT00029484Phase 2
- Shingles Prevention StudyCompletedNCT00007501Phase 3
- Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes ZosterCompletedNCT00006131Not applicable
- Evaluation of the Safety of Varivax® in Pediatric Renal Transplant RecipientsTerminatedNCT00005009Phase 1
- Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic NeuralgiaCompletedNCT00004390Phase 3
- A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune SystemsCompletedNCT00002315Phase 3
- Dextromethorphan Versus Placebo for Neuropathic PainCompletedNCT00001344Phase 2
- Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had ChickenpoxCompletedNCT00001125Phase 1